BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

Overview Fund Activity

26 hedge funds and large institutions have $22.9M invested in ProShares Ultra NASDAQ Biotechnology in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 8 closing their positions.

Holders
26
Holders Change
+1
Holders Change %
+4%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
9
Reduced
3
Closed
8
Calls
$5.02M
Puts
$3.93M
Net Calls
+$1.09M
Net Calls Change
+$2.19M

Top Buyers

1
GWM
1
Geneos Wealth Management
Colorado
$6.35M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$3.68M
3
HF
3
HRT Financial
New York
$3.21M
4
BG
4
Bellevue Group
Switzerland
$1.54M
5
TRCT
5
Tower Research Capital (TRC)
New York
$1.32M

Top Sellers

1
CIC
1
Chase Investment Counsel
Virginia
$0
2
BNP Paribas Financial Markets
2
BNP Paribas Financial Markets
France
$10.3K
3
UBS Group
3
UBS Group
Switzerland
$38K
4
PNC Financial Services Group
4
PNC Financial Services Group
Pennsylvania
$0
5
ASN
5
Advisory Services Network
Georgia
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
IA
26
IFP Advisors
Florida
$8K – – –
CIC
27
Chase Investment Counsel
Virginia
– -$1.97M -46,396 Closed
PNC Financial Services Group
28
PNC Financial Services Group
Pennsylvania
– -$49K -1,145 Closed
TC
29
Truvestments Capital
Florida
– -$32K -750 Closed
EW
30
Evoke Wealth
California
– -$29.8K -700 Closed
ASN
31
Advisory Services Network
Georgia
– -$35K -671 Closed
Simplex Trading
32
Simplex Trading
Illinois
– -$14K -331 Closed
CAPTRUST Financial Advisors
33
CAPTRUST Financial Advisors
North Carolina
– -$8K -180 Closed
Citigroup
34
Citigroup
New York
– -$5K -120 Closed
1
2